Symfo

Symfo, a leading provider of electronic patient reported outcome (ePRO) solutions for clinical trials, announced today the release of its newest handheld device, the SymPhone eDiary.

In order to better meet the needs of its customers, Symfo has recently developed SymPhone, a Java (J2ME) smartphone supporting Unicode and capable of recording patient data the same way as the SymQuest eDiary.

"We've spent the past twelve months working closely with our partner base and existing customers, listening closely to their feedback," said Serge Bodart, Symfo's CEO. "The release of the SymPhone product is a definitive step in the implementation of our product strategy which will allow Symfo to participate in a broader range of clinical studies throughout the world. With SymPhone, we'll be able to reach segments of patient populations that do not have immediate access to landline technology."

This smartphone-based system uses secure GSM (Global System Mobile) wireless technology for data transfers, and is suited for use in countries where the mobile telecommunications network is more readily available than the landline infrastructure. GSM is the most popular standard for mobile phones today, and is used by over 2 billion people across more than 212 countries and territories throughout the world.

To transmit data, patients use the GSM data call feature integrated in the SymPhone eDiary. After the information is entered, the SymPhone connects automatically to a pre-programmed number and the data gets sent immediately to Symfo's central server, where sponsors and site personnel login to view patient data and monitor patient compliance. Information can easily be retrieved in a variety of formats and integrated directly into existing clinical data management systems.

SymPhone can be used to record either short or long questionnaires by study subjects in real-time, allowing for higher quality data, and improved patient compliance.

ABOUT SYMFO
Symfo is an international organization specializing in electronic patient diary solutions, including the SymPro electronic patient diary, the SymQuest Palm-based diary and the SymVoice IVR. They are all simple to use and affordable solutions enabling study participants to easily implement electronic patient diaries in all phases of clinical trials and post-marketing studies.

For further details, please visit www.symfo.com.